Company / Working Capital
Glaukos Corp. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$373.7M
FY2025
5-year range
$321.4M / $422.8M
FY2021-FY2025
Trend
-0.3%
vs FY2024
Sector context
#82 of 165
Health Care
What the data says
At $374M, Glaukos Corp.'s working capital ranks #82 of 165 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $103M in FY2016 to $423M in FY2021.
Based on SEC 10-K filings.
$374M in FY2025 with a 5-year CAGR of -2.3%.
Improved from $321M to $374M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +0.2%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Sector benchmark
#82 of 165 in Health CareTop 50% of 165This company $373.7M Sector average $814.4M
▼
-54.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.3%, indicating a declining trend.
- In FY2025, working capital decreased 0.3% year-over-year.
- Ranks #82 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $373.7M | -0.3% |
| FY2024 | $374.7M | +16.6% |
| FY2023 | $321.4M | -13.5% |
| FY2022 | $371.5M | -12.1% |
| FY2021 | $422.8M | +0.7% |
| FY2020 | $419.7M | +104.6% |
| FY2019 | $205.2M | +40.3% |
| FY2018 | $146.2M | +19.2% |
| FY2017 | $122.7M | +19.0% |
| FY2016 | $103.1M | +23.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026